HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

NCT00792727 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2015-06-04

No results posted yet for this study

Summary

Ketoprofen in a topical patch formulation has been demonstrated to be effective for treating mild to moderate pain caused by various musculoskeletal disorders.

Conditions

  • Osteoarthritis of the Knee

Interventions

DRUG

ketoprofen Patch

2 topical patches applied once daily for 28 days

OTHER

Placebo Patch

2 topical placebo patches applied once daily for 28 days

Sponsors & Collaborators

  • Hisamitsu Pharmaceutical Co., Inc.

    lead INDUSTRY

Principal Investigators

  • Mr. Kenichi Furuta · Hisamitsu Pharmaceutical Co., Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2008-04-30
Completion
2008-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00792727 on ClinicalTrials.gov